Clinical Trial Update: A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder [Phase 2]

View source ↗

Summary

GlaxoSmithKline completed a Phase 2 trial comparing GW679769 to placebo in women with overactive bladder. The update indicates the trial is completed, but the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• GW679769

Snippet

Sponsor: GlaxoSmithKline | Conditions: Incontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder | Phase 2 | Status: COMPLETED